You are here

  • Home
  • Archive
  • Volume 4, Issue 8
  • Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

Article metrics

Article menu

Download PDFPDF

XML
Respiratory medicine
Research
Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 20181059118
Feb 20181029334
Mar 201816413529
Apr 201814613842
May 201813911942
Jun 201812610838
Jul 20181089625
Aug 201812711126
Sep 201813610227
Oct 201816413838
Nov 201819017049
Dec 201814713528
Jan 201914513633
Feb 201914813425
Mar 201917916139
Apr 20191189624
May 201918616737
Jun 201916515440
Jul 201911210839
Aug 201910610025
Oct 201913913128
Nov 201911410839
Dec 2019958527
Jan 202011211233
Feb 2020948640
Mar 202011511128
May 2020595554
Jun 2020575721
Jul 2020494716
Aug 2020777423
Sep 2020555322
Oct 2020877734
Nov 2020898031
Dec 2020686821
Jan 2021655616
Feb 2021686623
Mar 2021797721
Apr 2021858330
May 2021949726
Jun 2021808120
Jul 2021818731
Aug 2021858626
Sep 2021939543
Oct 2021787337
Nov 2021667036
Dec 2021869015
Jan 20229810624
Feb 20229510235
Mar 202217718324
Apr 202213412338
May 202213112526
Jun 202210210025
Jul 202213812928
Aug 202215214718
Sep 2022949121
Oct 20221039830
Nov 2022929317
Dec 202210711022
Jan 2023939224
Feb 2023798414
Mar 2023969715
Apr 2023646623
May 2023767519
Jun 2023808213
Jul 2023707322
Aug 2023716920
Sep 2023888315
Oct 2023919221
Nov 202398868
Dec 20231108621
Jan 2024444410
Feb 20242616428
Mar 20241159088
Apr 2024494815
Total789172352063